In this study, we combined the ECM3 signature and the IFN metagene in analysis of patients with early HGBC in order to investigate a novel molecular classifier with prognostic ability, which reflects the structural and immunological aspects of the TME. The gene discussed is IFNA1; the disease is Hemoglobin C Measurement.